Adam S Duerfeldt

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Venues

Future medicinal chemistry

Journal of medicinal chemistry

Microbiology spectrum

Journal of bacteriology

University of Oklahoma

University of Kansas (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Oklahoma

United States

Assistant Professor :: Chemistry & Biochemistry

Education History

University of Kansas

United States

PHD :: Medicinal Chemistry

Publications

Bo Hu, Jian-Xing Ma, Adam S Duerfeldt
The cGAS-STING pathway in diabetic retinopathy and age-related macular degeneration. Future medicinal chemistry 15 (8) (2023)
Bo Hu, Jian-Xing Ma, Adam S Duerfeldt
The cGAS-STING pathway in diabetic retinopathy and age-related macular degeneration. Future medicinal chemistry 15 (8) (2023)
Bo Hu, Jian-Xing Ma, Adam S Duerfeldt
The cGAS-STING pathway in diabetic retinopathy and age-related macular degeneration. Future medicinal chemistry 15 (8) (2023)
Bo Hu, Jian-Xing Ma, Adam S Duerfeldt
The cGAS-STING pathway in diabetic retinopathy and age-related macular degeneration. Future medicinal chemistry (2023)
Bo Hu, Jian-Xing Ma, Adam S Duerfeldt
The cGAS-STING pathway in diabetic retinopathy and age-related macular degeneration. Future medicinal chemistry 15 (8) (2023)
Ziwei Hu, Inga V Leus, Brinda Chandar, Bradley S Sherborne, Quentin P Avila, Valentin V Rybenkov, Helen I Zgurskaya, Adam S Duerfeldt
Correction to "Structure-Uptake Relationship Studies of Oxazolidinones in Gram-Negative ESKAPE Pathogens". Journal of medicinal chemistry (2023)
Julia J Lee, Ziwei Hu, Yuhong Anna Wang, Dinesh Nath, Wentao Liang, Yi Cui, Jian-Xing Ma, Adam S Duerfeldt
Design, Synthesis, and Structure-Activity Relationships of Biaryl Anilines as Subtype-Selective PPAR-alpha Agonists. ACS medicinal chemistry letters 14 (6) (2023)
Kate R Fortney, Sara N Smith, Julia J van Rensburg, Julie A Brothwell, Jessi J Gardner, Barry P Katz, Nagib Ahsan, Adam S Duerfeldt, Harry L T Mobley, Stanley M Spinola
CpxA Phosphatase Inhibitor Activates CpxRA and Is a Potential Treatment for Uropathogenic Escherichia coli in a Murine Model of Infection. Microbiology spectrum 10 (2) (2022)
Ziwei Hu, Inga V Leus, Brinda Chandar, Bradley S Sherborne, Quentin P Avila, Valentin V Rybenkov, Helen I Zgurskaya, Adam S Duerfeldt
Structure-Uptake Relationship Studies of Oxazolidinones in Gram-Negative ESKAPE Pathogens. Journal of medicinal chemistry 65 (20) (2022)
Catherine E Bishop, Tyler M Shadid, Nathan P Lavey, Megan L Kempher, Jimmy D Ballard, Adam S Duerfeldt
Identification of ClpP Dual Isoform Disruption as an Anti-sporulation Strategy for Clostridioides difficile. Journal of bacteriology (2021)
Xiaozheng Dou, Dinesh Nath, Henry Shin, Elmar Nurmemmedov, Philip C Bourne, Jian-Xing Ma, Adam S Duerfeldt
Evolution of a 4-Benzyloxy-benzylamino Chemotype to Provide Efficacious, Potent, and Isoform Selective PPARα Agonists as Leads for Retinal Disorders. Journal of medicinal chemistry 63 (6) (2020)
Xiaozheng Dou, Adam S Duerfeldt
Small-Molecule Modulation of PPARs for the Treatment of Prevalent Vascular Retinal Diseases. International journal of molecular sciences 21 (23) (2020)
Nanette L S Que, Vincent M Crowley, Adam S Duerfeldt, Jinbo Zhao, Caitlin N Kent, Brian S J Blagg, Daniel T Gewirth
Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding. Journal of medicinal chemistry 61 (7) (2018)
Nathan P Lavey, Tyler Shadid, Jimmy D Ballard, Adam S Duerfeldt
Clostridium difficile ClpP Homologues are Capable of Uncoupled Activity and Exhibit Different Levels of Susceptibility to Acyldepsipeptide Modulation. ACS infectious diseases 5 (1) (2018)

Adam S Duerfeldt.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Adam S Duerfeldt